ArticleCancer immunology, immunotherapy : CII2026

Therapeutic targeting of CD47 using a tri-specific NK cell engager to inhibit multiple myeloma.

Ratchaneewan Sumankan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.